Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's
  • India

    Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's

    Siddhant Pandey
    Written by
    Siddhant Pandey
    Twitter
    Last updated on Oct 25, 2020, 05:12 pm
    Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's
  • Phase II clinical trials for the Russian COVID-19 vaccine, Sputnik V, will have 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) has told Sputnik.

    Sputnik V is the first vaccine for COVID-19 to have been registered.

    The pharmaceutical company Dr. Reddy's has struck a deal to conduct vaccine trials and distribution of Sputnik V in India.

  • In this article
    100 subjects for Phase II trial; 1,400 for Phase III DCGI's expert committee had initially rejected Dr. Reddy's trial proposal Vaccine developed by RDIF, Gamaleya institute Over 78.6 lakh contracted COVID-19 in India
  • Details

    100 subjects for Phase II trial; 1,400 for Phase III

    100 subjects for Phase II trial; 1,400 for Phase III
  • The DCGI granted permission to Dr. Reddy's for the trial, however, the date/time will be determined by the company, Mint reported.

    The firm may proceed to Phase III trial after submitting the safety and immunogenicity data of Phase II, an official said.

    Dr. Reddy's has said the Phase II trial "would include 100 subjects and for Phase III, it would take 1,400 subjects."

  • Approval

    DCGI's expert committee had initially rejected Dr. Reddy's trial proposal

  • Earlier on October 5, the Subject Expert Committee (SEC) had evaluated Dr. Reddy's previous application and directed the company to submit a fresh application with revised protocol and more information.

    On October 13, the company had submitted the fresh application seeking approval to conduct Phase II and III trials for Sputnik V, a human adenoviral vector vaccine.

  • Background

    Vaccine developed by RDIF, Gamaleya institute

    Vaccine developed by RDIF, Gamaleya institute
  • Sputnik V has been developed jointly by the Russian Direct Investment Fund (RDIF) and the Gamaleya National Research Center of Epidemiology and Microbiology.

    It was registered by Russia's Health Ministry on August 11.

    In September, Dr. Reddy's had entered a partnership with RDIF for 100 million doses of the potential vaccine, which has been shown to induce a strong immune response among the participants.

  • Outbreak

    Over 78.6 lakh contracted COVID-19 in India

  • As of Sunday morning, India reported a total of 78,64,811 COVID-19 cases, after witnessing a spike of 50,129 cases, according to the Union Health Ministry's data.

    Since the beginning of the pandemic, 70,78,123 patients have recovered, while 6,68,154 of the total cases are active infections.

    The death toll climbed to 1,18,534 with 578 more fatalities in the past 24 hours.

  • Vaccine
  • Health Ministry
  • Union Health Ministry
  • Coronavirus
  • Russian Direct Investment Fund
  •  
Latest News
  • #HealthBytes: Carpal tunnel syndrome - its causes, symptoms, and prevention
    #HealthBytes: Carpal tunnel syndrome - its causes, symptoms, and prevention
    Lifestyle
  • Premier League, Chelsea 0-0 Manchester United: Records broken
    Premier League, Chelsea 0-0 Manchester United: Records broken
    Sports
  • Will Smith's new docuseries harps on America's birth of citizenship
    Will Smith's new docuseries harps on America's birth of citizenship
    Entertainment
  • #HealthBytes: A beginner's guide to working out at home
    #HealthBytes: A beginner's guide to working out at home
    Lifestyle
  • Five types of protein powders that you should know about
    Five types of protein powders that you should know about
    Lifestyle
Related Timelines
  • Coronavirus: India's tally reaches 10.77 million with 11K new cases
    Coronavirus: India's tally reaches 10.77 million with 11K new cases
    India
  • Coronavirus: India's tally reaches 10.62 million with 14K+ new cases
    Coronavirus: India's tally reaches 10.62 million with 14K+ new cases
    India
  • Coronavirus: India's tally reaches 10.57 million with 14K new cases
    Coronavirus: India's tally reaches 10.57 million with 14K new cases
    India
  • COVID-19 vaccine: India to produce 300 million Sputnik V doses
    COVID-19 vaccine: India to produce 300 million Sputnik V doses
    Science
Trending Topics
ISRO Vaccine Farmers Protest
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News YouTube Hollywood News WhatsApp Bollywood News ISRO Yoga Honda Batman Football News
BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Royal Challengers Bangalore Toyota Fashion Tips Farmers Protest Mohammed Bin Salman
Mercedes Europa League Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics Avengers Neha Kakkar
Premier League Big Bang Theory X-Men TATA
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021